Zoetis (ZTS)
(Delayed Data from NYSE)
$180.59 USD
-1.83 (-1.00%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $180.62 +0.03 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
ZTS 180.59 -1.83(-1.00%)
Will ZTS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZTS
UTHR or ZTS: Which Is the Better Value Stock Right Now?
Zoetis (ZTS) Advances While Market Declines: Some Information for Investors
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know
Unveiling Zoetis (ZTS) Q2 Outlook: Wall Street Estimates for Key Metrics
Zoetis (ZTS) to Report Q2 Earnings: What's in the Cards?
Other News for ZTS
Strong Buy on Zoetis Amid Share Repurchase and Solid Growth Prospects
My Top 15 High-Growth Dividend Stocks For August 2024
Zoetis Announces Authorization of Multi-Year $6 Billion Share Repurchase Program
Zoetis Announces $6 Billion Flexible Share Buyback Plan
Zoetis announces authorization of $6B share repurchase program